One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration

PURPOSE: To investigate 1-year visual and anatomic outcomes of intravitreal aflibercept for neovascular age-related macular degeneration (nAMD) given at a fixed 8-weekly interval. METHODS: Retrospective, single-practice data analysis from an electronic medical record system of 255 eyes (223 patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eye (Lond)
Hlavní autoři: Almuhtaseb, H, Kanavati, S, Rufai, S R, Lotery, A J
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2017
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518840/
https://ncbi.nlm.nih.gov/pubmed/28186507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2017.6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky